全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Base Composition Characteristics of Mammalian miRNAs

DOI: 10.1155/2013/951570

Full-Text   Cite this paper   Add to My Lib

Abstract:

MicroRNAs (miRNAs) are short RNA sequences that repress protein synthesis by either inhibiting the translation of messenger RNA (mRNA) or increasing mRNA degradation. Endogenous miRNAs have been found in various organisms, including animals, plants, and viruses. Mammalian miRNAs are evolutionarily conserved, are scattered throughout chromosomes, and play an important role in the immune response and the onset of cancer. For this study, the author explored the base composition characteristics of miRNA genes from the six mammalian species that contain the largest number of known miRNAs. It was found that mammalian miRNAs are evolutionarily conserved and GU-rich. Interestingly, in the miRNA sequences investigated, A residues are clearly the most frequent occupants of positions 2 and 3 of the 5′ end of miRNAs. Unlike G and U residues that may pair with C/U and A/G, respectively, A residues can only pair with U residues of target mRNAs, which may augment the recognition specificity of the 5′ seed region. 1. Introduction MicroRNAs (miRNAs) are single-stranded, short (15–27 nucleotides) RNA sequences that repress protein synthesis via base pairing to some portion of a messenger RNA (mRNA), such as the 3′ untranslated region (3′UTR), the 5′ untranslated region (5′UTR), or the coding region [1, 2]. Endogenous miRNAs have been found in various organisms, including animals, plants, and viruses. In mammals, precursor miRNAs (pre-miRNAs) 60–100 nucleotides in length form a hairpin stem-loop structure and are processed by Dicer, a highly conserved RNase III family endonuclease that is found in almost all eukaryotic organisms [3, 4]. This processing yields a miRNA?: miRNA duplex that is approximately 21 nucleotides long. One or both of the duplex’s short RNA strands is incorporated into RNA-induced silencing complexes (RISCs, which are composed of Dicer, Argonaute, and other nonspecified proteins) and functions as a mature miRNA that can base pair with mRNA targets, inducing either the degradation or translational repression of the mRNA [3, 4]. The regulation of miRNA is essential for organisms because miRNA plays critical roles in numerous biological processes, including the proliferation and differentiation of cells, as well as apoptosis. It is predicted that mammalian miRNAs can regulate approximately 30% of protein-coding genes [4]. The dysfunctional posttranscriptional modulation of gene expression caused by miRNAs has been related to diseases such as cancer and neurodegenerative disorders [5–8]. The investigation of miRNAs and their gene targets has thus

References

[1]  J. S. Ross, J. A. Carlson, and G. Brock, “miRNA: the new gene silencer,” American Journal of Clinical Pathology, vol. 128, no. 5, pp. 830–836, 2007.
[2]  C. K. Sen and S. Roy, “miRNA: licensed to kill the messenger,” DNA and Cell Biology, vol. 26, no. 4, pp. 193–194, 2007.
[3]  A. Grimson, K. K. H. Farh, W. K. Johnston, P. Garrett-Engele, L. P. Lim, and D. P. Bartel, “MicroRNA targeting specificity in mammals: determinants beyond seed pairing,” Molecular Cell, vol. 27, no. 1, pp. 91–105, 2007.
[4]  W. Filipowicz, S. N. Bhattacharyya, and N. Sonenberg, “Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?” Nature Reviews Genetics, vol. 9, no. 2, pp. 102–114, 2008.
[5]  Y. Tanaka and T. Kozu, “MiRNA in disease and therapeutic development,” Tanpakushitsu Kakusan Koso, vol. 51, no. 16, pp. 2509–2514, 2006.
[6]  J. Weiler, J. Hunziker, and J. Hall, “Anti-miRNA oligonucleotides (AMOs): ammunition to target miRNAs implicated in human disease?” Gene Therapy, vol. 13, no. 6, pp. 496–502, 2006.
[7]  C. Jay, J. Nemunaitis, P. Chen, P. Fulgham, and A. W. Tong, “miRNA profiling for diagnosis and prognosis of human cancer,” DNA and Cell Biology, vol. 26, no. 5, pp. 293–300, 2007.
[8]  T. H. Thai, P. A. Christiansen, and G. C. Tsokos, “Is there a link between dysregulated miRNA expression and disease?” Discovery Medicine, vol. 10, no. 52, pp. 184–194, 2010.
[9]  F. Ahmed, H. R. Ansari, and G. P. S. Raghava, “Prediction of guide strand of microRNAs from its sequence and secondary structure,” BMC Bioinformatics, vol. 10, article 105, 2009.
[10]  Z. Hu, “Insight into microRNA regulation by analyzing the characteristics of their targets in humans,” BMC Genomics, vol. 10, article 594, 2009.
[11]  M. Brameier, “Genome-wide comparative analysis of microRNAs in three non-human primates,” BMC Research Notes, vol. 3, article 64, 2010.
[12]  G. M. Borchert, N. W. Holton, J. D. Williams, et al., “Comprehensive analysis of microRNA genomic loci identifies pervasive repetitive-element origins,” Mobile Genetic Elements, vol. 1, pp. 8–17, 2011.
[13]  M. Schnall-Levin, O. S. Rissland, W. K. Johnston, N. Perrimon, D. P. Bartel, and B. Berger, “Unusually effective microRNA targeting within repeat-rich coding regions of mammalian mRNAs,” Genome Research, vol. 21, no. 9, pp. 1395–1403, 2011.
[14]  K. Gkirtzou, I. Tsamardinos, P. Tsakalides, and P. Poirazi, “MatureBayes: a probabilistic algorithm for identifying the mature miRNA within novel precursors,” PLoS ONE, vol. 5, no. 8, Article ID e11843, 2010.
[15]  Z. Z. Wang, B. S. Gong, H. K. Wang et al., “MicroRNA regulation constrains the organization of target genes on mammalian chromosomes,” FEBS Letters, vol. 585, no. 12, pp. 1897–1904, 2011.
[16]  S. Griffiths-Jones, “miRBase: the microRNA sequence database,” Methods in Molecular Biology, vol. 342, pp. 129–138, 2006.
[17]  S. Griffiths-Jones, R. J. Grocock, S. van Dongen, A. Bateman, and A. J. Enright, “miRBase: microRNA sequences, targets and gene nomenclature,” Nucleic Acids Research, vol. 34, pp. D140–D144, 2006.
[18]  S. Griffiths-Jones, H. K. Saini, S. Van Dongen, and A. J. Enright, “miRBase: tools for microRNA genomics,” Nucleic Acids Research, vol. 36, no. 1, pp. D154–D158, 2008.
[19]  A. Kozomara and S. Griffiths-Jones, “MiRBase: integrating microRNA annotation and deep-sequencing data,” Nucleic Acids Research, vol. 39, no. 1, pp. D152–D157, 2011.
[20]  N. C. Lau, L. P. Lim, E. G. Weinstein, and D. P. Bartel, “An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans,” Science, vol. 294, no. 5543, pp. 858–862, 2001.
[21]  J. G. Doench and P. A. Sharp, “Specificity of microRNA target selection in translational repression,” Genes and Development, vol. 18, no. 5, pp. 504–511, 2004.
[22]  J. Brennecke, A. Stark, R. B. Russell, and S. M. Cohen, “Principles of microRNA-target recognition,” PLoS Biology, vol. 3, no. 3, p. e85, 2005.
[23]  B. P. Lewis, C. B. Burge, and D. P. Bartel, “Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets,” Cell, vol. 120, no. 1, pp. 15–20, 2005.
[24]  C. B. Nielsen, N. Shomron, R. Sandberg, E. Hornstein, J. Kitzman, and C. B. Burge, “Determinants of targeting by endogenous and exogenous microRNAs and siRNAs,” RNA, vol. 13, no. 11, pp. 1894–1910, 2007.
[25]  I. Lee, S. S. Ajay, J. I. Yook et al., “New class of microRNA targets containing simultaneous 5′-UTR and 3′-UTR interaction sites,” Genome Research, vol. 19, no. 7, pp. 1175–1183, 2009.
[26]  E. Borenstein and E. Ruppin, “Direct evolution of genetic robustness in microRNA,” Proceedings of the National Academy of Sciences of the United States of America, vol. 103, no. 17, pp. 6593–6598, 2006.

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133